Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson’s disease
- 20 February 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 342 (4) , 1034-1039
- https://doi.org/10.1016/j.bbrc.2006.02.051
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patientsActa Neurologica Scandinavica, 2009
- Amyloid Fibril Formation of α-Synuclein Is Accelerated by Preformed Amyloid Seeds of Other ProteinsPublished by Elsevier ,2005
- Biomarkers of neurodegenerative disorders: How good are they?Cell Research, 2004
- Monoglucosylated glycans in the secreted human complement component C3: implications for protein biosynthesis and structureFEBS Letters, 2004
- HUPO Initiatives Relevant to Clinical ProteomicsMolecular & Cellular Proteomics, 2004
- Mutant genes responsible for Parkinson's diseaseCurrent Opinion in Pharmacology, 2004
- Mass spectrometry-based proteomicsNature, 2003
- Serum Amyloid P Component Binding to C4b-binding ProteinJournal of Biological Chemistry, 1995
- High resolution two-dimensional electrophoresis of basic as well as acidic proteinsCell, 1977
- Protein Purification by Elution Convection ElectrophoresisScience, 1964